A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations - Fiedler, Walter; Kayser, Sabine (British journal of haematology, 2015)
Gesehen am 02.05.2017